Disclosure Regarding Forward-Looking Statements
Certain statements contained in this report or in other materials we have filed
or will file with the Securities and Exchange Commission (the "SEC") constitute
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended ("Securities Act"), Section 21E of the Securities
Exchange Act of 1934, as amended ("Exchange Act"), and the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements reflect our
expectations, estimates or projections concerning our possible or assumed future
results of operations, including, but not limited to, descriptions of our
business strategy, and the benefits we expect to achieve from our working
capital management initiative. These statements are often identified by the use
of words such as "believe," "expect," "anticipate," "may," "could," "estimate,"
"likely," "will," "intend," "predict," "plan," "should," or other similar
expressions. Forward-looking statements are not guarantees of performance or
results and involve a number of risks and uncertainties. Although we believe
that these forward-looking statements are based on reasonable assumptions and
estimates, there are many factors that could cause our actual results to differ
materially from those projected. These factors include the impact of volatility
of metals prices, the cyclical and seasonal aspects of our business, our ability
to effectively manage inventory levels, the impact of our substantial level of
indebtedness, the impact of the novel Coronavirus (COVID-19) pandemic on our
financial results and business, as well as those risk factors identified in our
Annual Report on Form 10-K for the fiscal year ended December 31, 2019, our
Annual Report on Form 10-K/A for the fiscal year ended December 31, 2019, Part
II Item 1A of our quarterly report on Form 10-Q for the quarter ended March 31,
2020, Part II Item 1A of our quarterly report on Form 10-Q for the quarter ended
June 30, 2020, and Part II Item 1A of this quarterly report on Form 10-Q for the
quarter ended September 30, 2020. All future written and oral forward-looking
statements by us or persons acting on our behalf are expressly qualified in
their entirety by the cautionary statements contained or referred to in this
section. Any forward-looking statement speaks only as of the date made. Except
as required by applicable laws, we undertake no obligation to update any
forward-looking statements to reflect events or circumstances in the future, to
reflect the occurrence of unanticipated events or for any other reason.
The following discussion should be read in conjunction with the Company's
Condensed Consolidated Financial Statements and related notes thereto in Item 1.
"Financial Statements (unaudited)".
Overview
A. M. Castle & Co., together with its subsidiaries (the "Company," "we" or
"us"), is a global distributor of specialty metals and supply chain services,
principally serving the producer durable equipment, commercial and military
aircraft, heavy equipment, industrial goods, and construction equipment sectors
of the global economy. The Company provides a broad range of product inventories
as well as value-added processing and supply chain services to a wide array of
customers, with a particular focus on the aerospace and defense, power
generation, mining, heavy industrial equipment, and general manufacturing
industries, as well as general engineering applications.
Impact of Coronavirus (COVID-19) Pandemic
Although there were some signs of recovery in the third quarter of 2020, the
significantly lower demand for the Company's products experienced in the prior
quarter continued into the third quarter as many of the industries the Company
serves continue to be impacted economically, some significantly, by the novel
coronavirus 2019 ("COVID-19") pandemic. The global health crisis caused by the
COVID-19 pandemic continues to result in a decline in orders from and shipments
to customers compared to pre-pandemic levels, as well as slower-than-normal
payments from customers and disruptions at certain of the Company's suppliers.
In addition, the pricing environment for the Company's products continues to be
extremely competitive with lower average price per ton sold in the third quarter
on both a quarter-over-quarter and year-over-year basis. The Company anticipates
the recovery in economic activity to pre-pandemic levels will be slower than
originally expected as its customers and suppliers struggle to return their own
businesses to pre-pandemic levels. The Company expects COVID-19 to continue to
have an unfavorable impact on its financial results and business in the fourth
quarter of 2020, which is historically a seasonally slow quarter, and into 2021.
To date, the Company has taken actions to maintain operations through the
pandemic and its network as a whole has remained operational, albeit at varying
levels of volume aligned to customer orders and forecasts. The Company has
prepared and regularly updates business continuity plans for ongoing operations
and has taken steps to adjust its business to match the deteriorating economic
conditions, including the implementation of enhanced
                                       24
--------------------------------------------------------------------------------
  Table of Contents
measures through its global supply and branch management teams to ensure the
Company is efficiently utilizing inventory on hand and inbound, as well as its
internal processing capabilities.
Given the expectation that the recovery to pre-pandemic levels may be longer
than originally expected, the Company has begun to implement a long-term,
permanently sustainable cost structure that does not rely on temporary cost
reduction measures as significantly as those relied on during the early stages
of the pandemic. The Company believes the permanent cost-cutting measures being
implemented will not only align the Company with current demand, but also better
prepare it for any market recovery once this pandemic has passed. Permanent
cost-cutting measures, which are estimated to reduce the Company's operating
expenses by at least $15.0 million on an annualized basis, primarily include
staff reductions through layoffs, which were implemented in conjunction with the
elimination of most of the temporary cost measures taken previously, including
the temporary reduction in employee hours and/or salaries, deferral of periodic
salary increases and/or incentive pay, and/or a combination of these actions. In
an effort to protect the health and safety of its employees, the Company has
adopted sanitization, social distancing and other behavioral best practices at
its locations, including remote work arrangements, reducing the number of people
in the Company's branch and corporate locations at any one time, and suspending
non-essential employee travel. At the outset of the COVID-19 pandemic, the
Company established a COVID-19 response team to closely monitor the local,
regional, and national situations that impact the Company's various branches,
monitor and advise on COVID-19 exposures and potential exposures within the
Company's workspaces, direct and implement health and safety plans and business
continuity plans, and establish pandemic-related guidelines and policies to best
protect the Castle team and its business, including responsible return-to-work
or restart plans. Variables that the Company is taking into consideration as
some branches and the Corporate office begin to return to normal operations
include local case trends, testing availability, number of employees and the
workstation layout, productivity and engagement concerns, and most importantly,
guidance and requirements from local, state, and federal government, medical and
scientific authorities.
In an effort to bolster its liquidity position and mitigate potentially
significant detriment to its business, the Company has and will continue to
pursue a variety of government-sponsored support programs, such as tax
deferrals, employment-related subsidies, government-backed loans and other
government relief available in the U.S. and in other countries in which it
operates. Actual relief under each of these measures varies in terms of timing
and availability as governments continue to define, implement, extend and/or
fund their relief programs.
The Company qualified under the "alternative size standard" for a forgivable
loan under the Paycheck Protection Program ("PPP") administered by the Small
Business Association (SBA) pursuant to the CARES Act. On April 28, 2020, the
Company entered into an unsecured PPP loan in the aggregate principal amount of
$10.0 million, which is to be used only for payroll expenses, rent, utilities,
mortgage interest, and interest on other pre-existing indebtedness (the "PPP
Loan"). After taking into account, among other things, the disruptions to the
Company's business activities caused by the COVID-19 pandemic, the completed
exchange offer and consent solicitation (the "Exchange Offer") to issue its
3.00% / 5.00% Convertible Senior Secured Paid-in-Kind ("PIK") Toggle Notes due
2024 (the "3.00% / 5.00% Convertible Notes") and shares of its common stock in
exchange for its 5.00% / 7.00% Convertible Senior Secured PIK Toggle Notes due
2022 (the "5.00% / 7.00% Convertible Notes"), its available, committed primary
sources of liquidity, and its lack of access to alternative sources of
liquidity, economic conditions at that time made this loan request necessary and
appropriate to support the Company's ongoing U.S. operations and mitigate
potentially significant detriment to the Company's business. Under the terms of
the CARES Act and the Paycheck Protection Program Flexibility Act passed on June
5, 2020 (the "PPPFA"), the PPP Loan, and interest accrued thereon, is
forgivable, partially or in full, subject to certain conditions, including the
extent to which the PPP Loan proceeds are used for permissible purposes within
the 24 week period following loan disbursement (which period was extended by the
PPPFA from the 8 week period originally allowed by the CARES Act). The Company
believes it has used the PPP Loan proceeds for permissible purposes only and
intends to apply for forgiveness of the full amount of the PPP Loan in
accordance with the terms of the PPP, the CARES Act and the PPPFA.
On June 24, 2020, the Company's French subsidiary entered into a €6,000 term
loan (the "France Term Loan"). The France Term Loan, which is fully guaranteed
by the French government, is part of a relief program related to the COVID-19
pandemic. Similar to the PPP Loan, economic conditions resulting from the
COVID-19 pandemic made this France Term Loan necessary and appropriate to
support the Company's ongoing operations in France and mitigate potentially
significant detriment to the Company's business in France. The France Term Loan,
which is evidenced by a term note with HSBC Bank, matures on June 24, 2021 and
bears no interest. However, in connection with the government guarantee of the
France Term Loan, the Company must pay a commission to the French government of
0.5% per annum of the principal loan balance. Under the terms of the France Term
Loan, the Company has the option to extend the maturity of the loan for a period
of up to five years. As of September 30, 2020, the Company has the intent and
ability to extend the maturity of the France Term Loan beyond twelve months
                                       25
--------------------------------------------------------------------------------
  Table of Contents
and has therefore included the entire outstanding principal balance of the
France Term Loan in long-term debt at the Condensed Consolidated Balance Sheets.
The Company will continue to actively monitor the situation as it relates to the
COVID-19 pandemic and may take further actions altering the Company's business
operations that we determine are in the best interests of the Company's
employees, customers, business partners, suppliers, and shareholders, or as
required by federal, state, or local authorities. It is not clear what the
potential effects any such alterations or modifications may have on the
Company's business, including the effects on the Company's customers, employees,
and prospects, or on the Company's financial results for the remainder of fiscal
2020 or beyond.
Results of Operations
The following tables set forth certain statement of operations data in each
period indicated:
                                                           Three Months Ended September 30,
                                                                                                                                     Favorable/
                                                     2020                                    2019                                   (Unfavorable)
                                                                                                                        Three Month             Three Month
(Dollar amounts in millions)                $            % of Net Sales            $            % of Net Sales           $ Change                % Change

Net sales                              $   79.5                 100.0  %       $ 136.1                 100.0  %       $      (56.6)                    (41.6) %
Cost of materials (exclusive of
depreciation)                              58.6                  73.7  %         103.0                  75.7  %               44.4                      43.1  %
Operating costs and expenses               31.5                  39.6  %          36.9                  27.1  %                5.4                      14.6  %
Operating loss                         $  (10.6)                (13.3) %       $  (3.8)                 (2.8) %       $       (6.8)                         n/m



                                                            Nine Months Ended September 30,
                                                                                                                                     Favorable/
                                                       2020                                  2019                                  (Unfavorable)
                                                                                                                         Six Month               Six Month
(Dollar amounts in millions)                  $            % of Net Sales           $            % of Net Sales           $ Change               % Change

Net sales                                $  290.9                100.0  %       $ 433.6                100.0  %       $      (142.7)                  (32.9) %
Cost of materials (exclusive of
depreciation)                               211.8                 72.8  %         323.9                 74.7  %               112.1                    34.6  %
Operating costs and expenses                 96.1                 33.0  %         114.9                 26.5  %                18.8                    16.4  %
Operating loss                           $  (17.1)                (5.9) %       $  (5.3)                (1.2) %       $       (11.8)                       n/m


Net Sales
Net sales of $79.5 million in the three months ended September 30, 2020
decreased $56.6 million, or 41.6%, compared to $136.1 million in the three
months ended September 30, 2019. Net sales of $290.9 million in the nine months
ended September 30, 2020 decreased $142.7 million, or 32.9%, compared to $433.6
million in the nine months ended September 30, 2019. The decrease in net sales
in both the three and nine months ended September 30, 2020 compared to the same
periods in the prior year was driven primarily by the macroeconomic impacts of
the COVID-19 pandemic, which worsened already soft industrial end markets and
further weakened demand for global aerospace products. The weakening of demand
within the aerospace market is largely attributable to the impact of the
COVID-19 pandemic on global air travel and the grounding of the Boeing 737 MAX,
for which some of the Company's locations have customers that supply content.
Tons sold per day for the Company's products decreased by 33.7% in the three
months ended September 30, 2020 compared to the same quarter in the prior year
and 31.4% in the nine months ended September 30, 2020 compared to the nine
months ended September 30, 2019.
In the three months ended September 30, 2020 and the nine months ended September
30, 2020, overall average selling prices of the Company's product mix sold
decreased 12.7% and 2.7%, respectively, compared to the same periods in 2019.
The macroeconomic impact of the COVID-19 pandemic has resulted in a decrease in
demand and availability of supply, which has led to increased price competition
for all of the Company's core products. With the exception of aluminum, which
had an increase in price per ton sold, the price per ton sold decreased for all
of the products the Company sells in the three months ended September 30, 2020
and the nine months ended September 30, 2020, compared to the same periods in
2019.
                                       26
--------------------------------------------------------------------------------
  Table of Contents
The Company expects a long and slow market recovery to pre-pandemic levels. As a
result, the Company believes that the unfavorable financial and business impacts
of the pandemic that were experienced in the second and third quarters of 2020
will continue into the fourth quarter of 2020 and into 2021 as the Company's
customers and suppliers continue to maintain reduced purchasing forecasts and
output. In turn, the Company's expects the decrease in demand and availability
and increase in competition in the markets that the Company serves to continue
for the remainder of 2020 and into 2021.
Cost of Materials
Cost of materials (exclusive of depreciation) was $58.6 million in the three
months ended September 30, 2020 compared to $103.0 million in the three months
ended September 30, 2019. The $44.4 million, or 43.1%, decrease in the third
quarter of 2020 compared to the third quarter of 2019 is primarily due to the
decrease in net sales volume compared to the same period last year. Cost of
materials (exclusive of depreciation) was 73.7% of net sales in the three months
ended September 30, 2020 compared to 75.7% of net sales in the three months
ended September 30, 2019.
Cost of materials (exclusive of depreciation) was $211.8 million in the nine
months ended September 30, 2020 compared to $323.9 million in the nine months
ended September 30, 2019, a decrease of $112.1 million, or 34.6%. Cost of
materials (exclusive of depreciation) was 72.8% of net sales in the nine months
ended September 30, 2020 compared to 74.7% of net sales in the nine months ended
September 30, 2019.
The Company's focus on selectively pursuing higher margin sales that are more
accretive to the business, particularly those including the Company's value
added service offerings, resulted in sales of products with higher gross
material margins (calculated as net sales less cost of materials divided by net
sales) in both the three and nine months ended September 30, 2019, compared to
the same periods last year. The Company expects its margins will remain
relatively stable for the remainder of 2020 as its improved inventory management
partially offsets the headwinds produced by reduced demand, a downward pricing
environment and the unfavorable impacts of the COVID-19 pandemic on the overall
global economy.
Operating Costs and Expenses and Operating Loss
In response to the unfavorable global economic conditions resulting from the
COVID-19 pandemic, the Company began early in the second quarter of 2020 to take
steps to align its operating costs and expenses with the decrease in customer
and supplier forecasts and output, including the temporary reduction in employee
hours and salaries, deferral of periodic salary increases and incentive pay, or
a combination of these actions. As a result of the slower-than-expected
recovery, the Company has elected to make many of the cost reduction steps
permanent as it moves toward a permanently sustainable cost structure aligned
for a longer period of reduced customer demand. The permanent steps taken by
management include reductions in discretionary spending and additional staff
reductions through layoffs at each of its branches and at its corporate offices.
In addition, for the safety of its employees, the Company has suspended
non-essential employee travel. The cost-cutting measures taken by the Company to
date have resulted in a significant decrease in operating costs and expenses in
the three and nine months ended September 30, 2020 compared to the same periods
last year. The Company expects the permanent cost-cutting measures taken, which
were primarily implemented in the latter half of September 2020, to result in a
further decrease in operating costs and expenses in future periods.

                                       27

--------------------------------------------------------------------------------


  Table of Contents
                                            Three Months Ended September 30,                                 Favorable/(Unfavorable)
                                                                                                     Three Month                          Three Month
 (Dollar amounts in millions)                   2020                   2019                           $ Change                              % Change
Warehouse, processing and delivery
expense                                 $            13.4          $     18.8          $                5.4                                         28.7  %
Sales, general and administrative
expense                                              13.5                16.0                           2.5                                         15.6  %
Depreciation expense                                  1.9                 2.1                           0.2                                          9.5  %
Impairment of goodwill                                2.7                   -                          (2.7)                                            n/m
Total operating costs and expenses      $            31.5          $     36.9          $                5.4                                         

14.6 %




Operating costs and expenses decreased by $5.4 million, or 14.6%, from $36.9
million in the three months ended September 30, 2019 to $31.5 million in the
three months ended September 30, 2020, primarily as a result of the following:
•Warehouse, processing and delivery expense decreased by $5.4 million primarily
due to a lower payroll and benefits costs and lower warehouse and freight costs
in the three months ended September 30, 2020 compared to the same period last
year. The 28.7% decrease was driven by cost cutting measures taken by the
Company in response to the COVID-19 pandemic, as well as lower sales volume.
•Sales, general and administrative expense decreased by $2.5 million, primarily
the result of lower payroll and benefits costs, as well as other reductions in
employee expenses and discretionary spending in the three months ended September
30, 2020 compared to the three months ended September 30, 2019 driven mainly by
the cost cutting measures taken by the Company in response to the COVID-19
pandemic, including staff reductions, reductions in employee work hours and/or
salaries, furloughs, temporary layoffs, deferral of periodic salary increases
and/or incentive pay, or a combination of these actions. The decreases were
partially offset by severance costs of approximately $0.7 million and by legal
and other direct fees of $0.3 million associated with the filing of a
registration statement for the registration of additional shares of the
Company's common stock.
•As described in Note 5, Goodwill and Other Intangibles, to the Notes to the
Condensed Consolidated Financial Statements, due to the ongoing unfavorable
economic impacts of the COVID-19 pandemic, which represented facts and
circumstances indicating that it was likely that its goodwill and indefinite
lived trade name intangible assets could be impaired, the Company performed an
assessment of its goodwill as of September 30, 2020. As a result of the goodwill
impairment assessment, the Company recorded a non-cash impairment charge of $2.7
million during the third quarter of fiscal 2020. The Company has no remaining
goodwill as a result of the charge recognized in the period. This non-cash
impairment charge does not result in any future cash expenditures, impact
liquidity, affect ongoing business or financial performance of the Company,
impact compliance with our lending arrangements or reduce borrowing capacity.
                                           Nine Months Ended September 30,                                Favorable/(Unfavorable)
                                                                                                  Three Month                          Three Month
 (Dollar amounts in millions)                  2020                  2019                          $ Change                              % Change
Warehouse, processing and delivery
expense                                 $          45.6          $    59.6          $                14.0                                        23.5  %
Sales, general and administrative
expense                                            41.8               49.0                            7.2                                        14.7  %
Depreciation expense                                6.0                6.3                            0.3                                         4.8  %
Impairment of goodwill                              2.7                  -                           (2.7)                                           n/m

Total operating costs and expenses $ 96.1 $ 114.9

         $                18.8                                        16.4  %


Operating costs and expenses decreased by $18.8 million, or 16.4%, from $114.9
million in the nine months ended September 30, 2019 to $96.1 million in the nine
months ended September 30, 2020, primarily as a result of the following:
•Warehouse, processing and delivery expense decreased by $14.0 million primarily
due to lower payroll and benefits costs and lower warehouse and freight costs in
the nine months ended September 30, 2020 compared to the nine months ended
September 30, 2019. The 23.5% decrease was driven by cost cutting measures taken
by the Company beginning in the second quarter of 2020 in response to the
COVID-19 pandemic, as well as lower sales volume.
                                       28
--------------------------------------------------------------------------------
  Table of Contents
•Sales, general and administrative expense decreased by $7.2 million primarily
the result of lower payroll and benefits costs in the nine months ended
September 30, 2020 compared to nine months ended September 30, 2019 driven
mainly by the cost cutting measures taken by the Company in response to the
COVID-19 pandemic, including staff reductions, reductions in employee work hours
and/or salaries, furloughs, temporary layoffs, deferral of periodic salary
increases and/or incentive pay, or a combination of these actions. The decreases
were partially offset by legal and other direct fees associated with the
Exchange Offer in the amount of $1.4 million, severance costs of approximately
$0.7 million, and legal and other direct fees of $0.3 million associated with
the filing of a registration statement for the registration of additional shares
of the Company's common stock.
•As described above, the Company recorded a non-cash goodwill impairment charge
in the three and nine months ended September 30, 2020.
Operating loss in the three months ended September 30, 2020 was $10.6 million,
compared to $3.8 million in the three months ended September 30, 2019. Operating
loss in the nine months ended September 30, 2020 was $17.1 million, compared to
$5.3 million in the nine months ended September 30, 2019.
Other Income and Expense, Income Taxes and Net Loss
Interest expense, net was $5.1 million in the three months ended September 30,
2020, compared to $10.2 million in the three months ended September 30, 2019.
Interest expense includes the interest cost component of the net periodic
benefit cost of the Company's pension and post retirement benefits of $1.0
million in the three months ended September 30, 2020 and $1.3 million in the
three months ended September 30, 2019. As a result of the Exchange Offer, the
Company reduced the aggregate principal amount of its long-term debt by $94.5
million and expects to reduce its annual interest expense by over $10.0 million.
The decrease in interest expense in the three months ended September 30, 2020
compared to the three months ended September 30, 2019 is primarily due to a
decrease in the overall non-cash interest expense on outstanding convertible
debt as a result of the Exchange Offer of $2.0 million, a decrease in non-cash
amortization of the outstanding convertible debt of $2.2 million, and a decrease
in interest expense on the Company's variable rate revolving credit facility of
$0.7 million as a result of both a lower revolving credit facility borrowings
and a lower effective interest rate on revolving credit facility borrowings.
Interest expense, net was $20.1 million in the nine months ended September 30,
2020, compared to $29.5 million in the nine months ended September 30, 2019.
Interest expense includes the interest cost component of the net periodic
benefit cost of the Company's pension and post retirement benefits of $3.0
million in the nine months ended September 30, 2020 and $4.0 million in the nine
months ended September 30, 2019. The decrease in interest expense net in the
nine months ended September 30, 2020 compared to the nine months ended September
30, 2019 is primarily due to the decrease in interest expense in the second and
third quarters of 2020, for the reasons described above.
The unrealized gain on embedded conversion option of $2.0 million in the nine
months ended September 30, 2020 is the result of the mark-to-market adjustment
associated with the bifurcated embedded derivative liability of the Company's
3.00% / 5.00% Convertible Notes. As of June 30, 2020, the conversion option
qualifies for equity classification and the bifurcated derivative liability will
no longer need to be accounted for as a separate derivative on a prospective
basis from the date of reassessment. Any remaining debt discount that arose at
the date of debt issuance from the original bifurcation will continue to be
amortized through interest expense.
Other income, net was $0.3 million in the three months ended September 30, 2020,
compared to $0.7 million in the three months ended September 30, 2019. Included
in other income, net in the three months ended September 30, 2020 and the three
months ended September 30, 2019 was net pension benefit of $1.7 million and $1.5
million, respectively. The remaining other income, net for the comparative
periods is the result of foreign currency transaction gains and losses. The
Company recorded a net foreign currency loss of $1.3 million in the three months
ended September 30, 2020, of which $1.5 million was attributable to unrealized
losses on foreign currency transactions, partially offset by a $0.2 million
unrealized gain on intercompany loan, compared to a net foreign currency loss of
$0.8 million in the three months ended September 30, 2019, $0.3 million of which
was attributable to unrealized gains on foreign currency transactions and $0.5
million to an unrealized gain on intercompany loan.
                                       29
--------------------------------------------------------------------------------
  Table of Contents
Other income, net was $2.2 million in the nine months ended September 30, 2020,
compared to other income, net of $4.8 million in the nine months ended September
30, 2019. Included in other income, net in the nine months ended September 30,
2020 and the nine months ended September 30, 2019 was net pension benefit of
$5.0 million and $4.6 million, respectively. The remaining other income, net for
the comparative periods is the result of foreign currency transaction gains and
losses. The Company recorded a net foreign currency loss of $2.6 million in the
nine months ended September 30, 2020, of which $1.9 million is attributable to
unrealized losses on foreign currency transactions and $0.7 million is an
unrealized loss on intercompany loan, compared to a foreign currency gain of
$0.2 million in the nine months ended September 30, 2019, of which $0.4 was
attributable to an unrealized gain on intercompany loan, partially offset by a
$0.2 million unrealized loss on foreign currency transactions.
Loss before income taxes was $15.3 million in the three months ended September
30, 2020, compared to $13.3 million in the three months ended September 30,
2019. The decrease in the loss before income taxes in the three months ended
September 30, 2020 compared to the same period in the prior year was primarily
due to a $5.1 million decrease in interest expense, partially offset by an
increase in the Company's operating loss in the three months ended September 30,
2020 and the larger unfavorable impact of foreign currency in the three months
ended September 30, 2020, compared to the same period last year.
Loss before income taxes of $33.0 million in the nine months ended September 30,
2020 was virtually flat compared to the nine months ended September 30, 2019 as
the increase in the operating loss in the nine months ended September 30, 2020
compared to the same period in the prior year was offset by a decrease in
interest expense. Further, the decrease in other income, net, which was
primarily due to the net unfavorable impact of foreign currency in the nine
months ended September 30, 2020 compared to the nine months ended September 30,
2019, was offset by the impact of the unrealized gain on the embedded debt
conversion derivative liability recognized in the second quarter of 2020.
The Company recorded an income tax benefit of $0.6 million in the three months
ended September 30, 2020, compared to an income tax benefit of $1.1 million in
the three months ended September 30, 2019 and income tax benefit of $3.2 million
in the nine months ended September 30, 2020, compared to an income tax benefit
of $1.5 million in the nine months ended September 30, 2019. The Company's
effective tax rate is expressed as income tax expense as a percentage of loss
before income taxes. The effective tax rate in the three months ended September
30, 2020 was 3.7% as compared to 8.1% in the three months ended September 30,
2019 and 9.6% in the nine months ended September 30, 2020 as compared to 4.9% in
the nine months ended September 30, 2019. The change in the effective tax rate
between periods resulted from changes in the geographic mix and timing of income
or losses, the inclusion of foreign earnings under Internal Revenue Code ("IRC")
Section 951A, the impact of the foreign income tax rate differential and, for
the nine month period, the increase in the Company's net operating loss
carrybacks due to the CARES Act, which was recognized in the nine months ended
September 30, 2020.
Net loss was $14.7 million in the three months ended September 30, 2020,
compared to $12.2 million in the three months ended September 30, 2019, and
$29.8 million in the nine months ended September 30, 2020, compared to $28.5
million in the nine months ended September 30, 2019. Net loss in both the three
and nine months ended September 30, 2020 includes a non-cash goodwill impairment
charge of $2.7 million.
Liquidity and Capital Resources
Liquidity
Cash and cash equivalents increased (decreased) as follows:
                                                                        Nine Months Ended
                                                                          September 30,
(Dollar amounts in millions)                                        2020                    2019
Net cash provided by operating activities                   $        19.8              $        4.6
Net cash used in investing activities                                (2.3)                     (3.1)
Net cash provided by (used in) financing activities                   0.1                      (2.7)
Effect of exchange rate changes on cash and cash
equivalents                                                           0.2                         -
Net change in cash and cash equivalents                     $        17.8              $       (1.2)


The Company's principal sources of liquidity are cash provided by operations and
proceeds from borrowings under its revolving credit facilities. Given the
economic uncertainty and disruptions resulting from the COVID-19 pandemic, the
Company will continue to focus on maintaining liquidity to fund its normal
operations and appropriately aligning its working capital with the changing
economic conditions. In the second and third quarters of 2020, the average
                                       30
--------------------------------------------------------------------------------
  Table of Contents
receivable days outstanding increased from levels in previous quarters, which
the Company believes reflects some slowing in payments from customers due to the
financial uncertainties resulting from the COVID-19 pandemic. The Company has
fewer accounts receivables as of September 30, 2020 as a result of the decrease
in demand resulting from the COVID-19 pandemic, which has decreased its
borrowing base collateral attributable to accounts receivable under its
revolving credit facility and, in the near term, could result in less cash
provided by operations. Further decreases in the Company's accounts receivable
could result in further reductions in its borrowing base collateral and
therefore, the maximum amount it could borrow under its revolving credit
facility could decrease accordingly. The decrease in demand has also resulted in
a significant increase in average days sales in inventory in the third quarter
compared to the previous quarter. The Company is focused on maintaining
liquidity by purchasing a sufficient level of inventory to meet customer demand
while not carrying excess inventory and lowering overall stock levels throughout
the business. However, if the Company is unable to sufficiently manage its
inventory levels and it begins to carry excess inventory, its liquidity could be
unfavorably impacted. Conversely, a decrease in the Company's inventory could
result in a reduction in its borrowing base collateral attributable to inventory
and therefore, the maximum amount it could borrow under its revolving credit
facility could decrease accordingly.
The ongoing duration and severity of the COVID-19 pandemic could have a
significant unfavorable impact on the Company's suppliers' ability to deliver
products and services and its customers' ability to purchase goods and services
and pay their accounts receivable timely, if at all, which could have a
significant adverse effect on the Company's operations, financial condition and
liquidity. With the benefit of the various government-sponsored support programs
such as tax deferrals, employment-related subsidies, government-backed loans and
other government relief available in the U.S. and in other countries in which it
operates, including the PPP Loan received in April 2020 and the France Term Loan
received in June 2020, coupled with temporary and long-term cost-cutting
initiatives implemented by the Company, the Company expects it will be able to
maintain adequate liquidity and working capital to continue its normal
operations over the next 12 months (see Item 2 - Management's Discussion and
Analysis of Financial Condition and Results of Operations - Impact of
Coronavirus (COVID-19) Pandemic). However, given the current uncertain economic
conditions, there can be no assurance that the Company will be able to achieve
its strategic initiatives or obtain additional funding on favorable terms in the
future, which could have a significant adverse effect on its operations,
financial condition and liquidity.
Specific components of the change in working capital (defined as current assets
less current liabilities), are highlighted below:
•A decrease in accounts receivable at September 30, 2020 compared to December
31, 2019 resulted in a cash flow source of $27.9 million in the nine months
ended September 30, 2020, compared to a cash flow use of $8.4 million in the
nine months ended September 30, 2019. Average receivable days outstanding was
58.3 days in the nine months ended September 30, 2020 compared to 55.4 days for
the nine months ended September 30, 2019, which, the Company believes, reflects
some slowing in payments from customers due to the financial uncertainties
resulting from the COVID-19 pandemic. Although the Company expects slowness of
payments from customers to continue, the Company considered the economic impact
of the COVID-19 pandemic on the collectability of customer accounts receivable
and determined that no specific additional allowance for doubtful accounts was
required as of September 30, 2020. The full impact of the COVID-19 pandemic is
unknown and rapidly evolving. The Company will continue to analyze any financial
and commercial impacts of the COVID-19 pandemic, including any adverse impact
the COVID-19 pandemic may have on the collectability of customer accounts
receivable as well as the impact the level of accounts receivable may have on
its borrowing capacity under the ABL Credit Agreement.
•Lower inventory levels at September 30, 2020 compared to December 31, 2019
resulted in a cash flow source of $4.7 million in the nine months ended
September 30, 2020 compared to lower inventory levels at September 30, 2019
compared to December 31, 2018, which resulted in a cash flow source of $10.0
million in the nine months ended September 30, 2019. Average days sales in
inventory was 172.0 days for the nine months ended September 30, 2020 compared
to 133.4 days for the nine months ended September 30, 2019. The increase in
average days sales in inventory is primarily due to the impact of the COVID-19
pandemic, which caused a significant decrease in sales volume beginning in March
2020. As the Company expects the markets to remain soft due to the impacts of
the COVID-19 pandemic, it will continue to focus on managing inventory levels,
primarily by reducing aged inventories, lowering overall stock levels throughout
the business and the real-time facilitation of its branches in selling
higher-priced inventory. The Company will continue to monitor the impact its
inventory levels may have on its borrowing capacity under the ABL Credit
Agreement.
                                       31
--------------------------------------------------------------------------------
  Table of Contents
•A decrease in total accounts payable and accrued and other current liabilities
compared to December 31, 2019 resulted in a $1.9 million cash flow use in the
nine months ended September 30, 2020 compared to a cash flow source of $1.6
million in the nine months ended September 30, 2019. Accounts payable days
outstanding was 56.6 days for the nine months ended September 30, 2020 compared
to 41.7 days for the same period last year. The improving financial condition of
the Company prior to the impact of the COVID-19 pandemic, particularly the
recent completion of the Exchange Offer (defined below), had resulted in
improved credit terms with certain of its suppliers, including an extension of
net payment dates and/or credit limits. Additionally, as the Company continues
to align its cash flows in response to the economic impacts and uncertainties
caused by the COVID-19 pandemic, it expects some variability in the timing of
payments to vendors to continue.
Working capital and the balances of its significant components are as follows:
                                                               As of
                                                                                            Working Capital
                                                September 30,         December 31,             Increase
(Dollar amounts in millions)                        2020                  2019                (Decrease)
Working capital                                $      160.2          $      173.7          $        (13.5)
Cash and cash equivalents                              24.2                   6.4                    17.8
Accounts receivable                                    46.8                  74.7                   (27.9)
Inventories                                           140.1                 144.4                    (4.3)
Accounts payable                                       40.6                  41.7                     1.1
Accrued and other current liabilities                  10.8                  11.2                     0.4
Operating lease liabilities                             6.5                   6.5                       -


Approximately $12.7 million of the Company's consolidated cash and cash
equivalents balance of $24.2 million at September 30, 2020 resided in the United
States.
The decrease in net cash used in investing activities to $2.3 million during the
nine months ended September 30, 2020 from $3.1 million during the nine months
ended September 30, 2019 is due to a decrease in cash paid for capital
expenditures, primarily purchases of warehouse equipment. The Company expects
capital expenditures to be approximately $3.0 million for the full-year 2020.
During the nine months ended September 30, 2020, net cash provided by financing
activities of $0.1 million was attributable to net proceeds from long term
borrowings made by the Company, which were partially offset by net repayments of
short-term borrowings under the Company's foreign line of credit in France and
payments of debt restructuring costs. In the nine months ended September 30,
2020, the Company entered into two new long-term debt agreements (PPP Loan and
France Term Loan, discussed below), the proceeds of which were partially offset
by net repayments under its revolving credit facilities. During the nine months
ended September 30, 2019, the net cash used in financing activities of $2.7
million was primarily attributable to net principal repayments made by the
Company on its revolving credit facility, as well as net repayments of
short-term borrowings under the Company's foreign lines of credit.
Capital Resources
The Company's various credit arrangements are with well-established, global
lenders. The Company does not expect the COVID-19 pandemic will have a
significant impact on the ability of these lenders to continue to lend cash to
the Company pursuant to the credit arrangements that the Company has with these
lenders.
On August 31, 2017, the Company entered into the Revolving Credit and Security
Agreement with PNC Bank, National Association ("PNC") as lender and as
administrative and collateral agent (the "Agent"), and other lenders party
thereto (the "Original ABL Credit Agreement"). The Original ABL Credit Agreement
provided for a $125.0 million senior secured, revolving credit facility (the
"Revolving A Credit Facility"), under which the Company and four of its
subsidiaries each are borrowers (collectively, in such capacity, the
"Borrowers"). The obligations of the Borrowers have been guaranteed by the
subsidiaries of the Company named therein as guarantors. On June 1, 2018, the
Company entered into an Amendment No. 1 to ABL Credit Agreement (the "Credit
Agreement Amendment No. 1") by and among the Company, the Borrowers and
guarantors party thereto and the Agent and the other lenders party thereto,
which amended the Original ABL Credit Agreement to provide for additional
borrowing capacity. On March 27, 2020, the Company entered into an Amendment No.
2 to the Original ABL Credit Agreement (the "Credit Agreement Amendment No. 2)
by and among the Company, the Borrowers and guarantors party thereto and the
Agent and other lenders party thereto, which amended the Original ABL Credit
Agreement (as amended by
                                       32
--------------------------------------------------------------------------------
  Table of Contents
the Credit Agreement Amendment No. 1 and Credit Agreement Amendment No. 2, the
"ABL Credit Agreement") to permit the Exchange Offer (defined below) to proceed.
The ABL Credit Agreement provides for an additional $25.0 million last out
Revolving B Credit Facility (the "Revolving B Credit Facility" and together with
the Revolving A Credit Facility, the "Credit Facility") made available in part
by way of a participation in the Revolving B Credit Facility by certain of the
Company's stockholders. Borrowings under the Credit Facility will mature on
February 28, 2022.
Subject to certain exceptions and permitted encumbrances, the obligations under
the ABL Credit Agreement are secured by a first priority security interest in
substantially all of the assets of each of the Borrowers and certain
subsidiaries of the Company that are named as guarantors. The proceeds of the
advances under the ABL Credit Agreement may only be used to (i) pay certain fees
and expenses to the Agent and the lenders under the ABL Credit Agreement, (ii)
provide for the Borrowers' working capital needs and reimburse drawings under
letters of credit, (iii) repay the obligations under the Debtor-in-Possession
Revolving Credit and Security Agreement dated as of July 10, 2017, by and among
the Company, the lenders party thereto, and PNC, and certain other existing
indebtedness, and (iv) provide for the Borrowers' capital expenditure needs, in
accordance with the ABL Credit Agreement.
The Company may prepay its obligations under the ABL Credit Agreement at any
time without premium or penalty, and must apply the net proceeds of material
sales of collateral in prepayment of such obligations. Payments made must be
applied to the Company's obligations under the Revolving A Credit Facility, if
any, prior to its obligations under the Revolving B Credit Facility. In
connection with an early termination or permanent reduction of the Revolving A
Credit Facility prior to March 27, 2021, a 0.50% fee shall be due and, for the
period from March 28, 2021 through September 27, 2021, a 0.25% fee shall be due,
in each case in the amount of such commitment reduction, subject to reduction as
set forth in the ABL Credit Agreement. Indebtedness for borrowings under the ABL
Credit Agreement is subject to acceleration upon the occurrence of specified
defaults or events of default, including (i) failure to pay principal or
interest, (ii) the inaccuracy of any representation or warranty of a loan party,
(iii) failure by a loan party to perform certain covenants, (iv) defaults under
indebtedness owed to third parties, (v) certain liability producing events
relating to ERISA, (vi) the invalidity or impairment of the Agent's lien on its
collateral or of any applicable guarantee, and certain adverse
bankruptcy-related and (vii) certain adverse bankruptcy-related and other
events.
Interest on indebtedness under the Revolving A Credit Facility accrues at a
variable rate based on a grid with the highest interest rate being the
applicable LIBOR-based rate plus a margin of 3.0%, as set forth in the ABL
Credit Agreement. Interest on indebtedness under the Revolving B Credit Facility
accrues at a rate of 12.0% per annum, which will be paid-in-kind unless the
Company elects to pay such interest in cash and the Revolving B payment
conditions specified in the ABL Credit Agreement are satisfied. Additionally,
the Company must pay a monthly facility fee equal to the product of (i) 0.25%
per annum (or, if the average daily revolving facility usage is less than 50% of
the maximum revolving advance amount of the Credit Facility, 0.375% per annum)
multiplied by (ii) the amount by which the maximum advance amount of the Credit
Facility exceeds such average daily Credit Facility usage for such month.
Under the ABL Credit Agreement, the maximum borrowing capacity of the Revolving
A Credit Facility is based on the Company's borrowing base calculation. As of
September 30, 2020, the weighted average advance rates used in the borrowing
base calculation are 85.0% on eligible accounts receivable and 69.4% on eligible
inventory.
The Company's ABL Credit Agreement contains certain covenants and restrictions
customary to an asset-based revolving loan. Pursuant to the terms of the ABL
Credit Agreement, the PPP Loan and the France Term Loan shall be excluded for
all purposes from any covenant calculations.
The Company's ABL Credit Agreement contains a springing financial maintenance
covenant requiring the Company to maintain a Fixed Charge Coverage Ratio of 1.0
to 1.0 in any Covenant Testing Period (as defined in the ABL Credit Agreement)
when the Company's cash liquidity (as defined in the ABL Credit Agreement) is
less than $12.5 million for five consecutive days. The Company was not in a
Covenant Testing Period as of and for the three and nine months ended September
30, 2020.
Additionally, upon the occurrence and during the continuation of an event of
default or upon the failure of the Company to maintain cash liquidity (as
defined in the ABL Credit Agreement, inclusive of certain cash balances and the
additional unrestricted borrowing capacity shown below) in excess of $12.5
million, the lender has the right to take full dominion of the Company's cash
collections and apply these proceeds to outstanding loans under the ABL Credit
Agreement ("Cash Dominion"). A prolonged economic downturn due to the COVID-19
pandemic could result in the Company's cash liquidity decreasing to a level that
would cause Cash Dominion to occur and/or the Company to enter into a Covenant
Testing Period. The extent to which the COVID-19 pandemic will impact the
Company's
                                       33
--------------------------------------------------------------------------------
  Table of Contents
liquidity is currently unknown. Based on the Company's current cash projections,
taking into consideration the benefit of the various government-sponsored
support programs such as tax deferrals, employment-related subsidies,
government-backed loans and other government relief available in the U.S. and in
other countries in which it operates, including the PPP Loan received in April
2020, coupled with temporary and long-term cost-cutting initiatives implemented
by the Company, it does not anticipate that Cash Dominion will occur, or that it
will be in a Covenant Testing Period during the next 12 months.
On April 28, 2020, the Company entered into the PPP Loan, which provides
additional cash to be used for payroll costs, interest on mortgages, rent and
utilities. The Company intends to apply for forgiveness of the full amount of
the PPP Loan in accordance with the terms of the PPP and the CARES Act; however,
the Company cannot assure at this time that the PPP Loan will be fully forgiven.
On June 24, 2020, the Company's French subsidiary entered into the France Term
Loan, which is fully guaranteed by the French government, and provides
additional capital to support the Company's ongoing operations in France.
Considerable uncertainty exists with regards to the ultimate duration and
severity of the COVID-19 pandemic as well as the full extent of the impact that
the COVID-19 pandemic will have on the Company's business, operations and
financial condition. However, with the benefit of the various
government-sponsored support programs such as tax deferrals, employment-related
subsidies, government-backed loans and other government relief available in the
U.S. and in other countries in which it operates, including the PPP Loan
received in April 2020 and the France Term Loan received in June 2020, coupled
with the temporary and long-term cost-cutting initiatives implemented by the
Company, the Company believes that its existing cash balances, together with
cash generated from operations and proceeds from its various revolving credit
facilities, will be sufficient to fund its normal business operations and
service its debt over the next twelve months from the issuance of this report.
The Company's ability to borrow funds is dependent on its ability to maintain an
adequate borrowing base. Accordingly, if the Company does not generate
sufficient cash flow from operations to fund its working capital needs and
planned capital expenditures, and its availability is depleted, it may need to
take further actions, such as reducing or delaying capital investments,
strategic investments or other actions. A prolonged economic downturn due to the
COVID-19 pandemic could unfavorably impact the Company's ability to fund its
working capital needs through operating cash flows, which could result in a
reduction in its borrowing base. Although the extent to which the COVID-19
pandemic will impact the Company's operating cash flows and borrowing base is
currently unknown, the Company anticipates it will be able to maintain an
adequate borrowing base to support ongoing availability under its ABL Credit
Agreement.
Additional unrestricted borrowing capacity under the Revolving A Credit Facility
as of September 30, 2020 was as follows (in millions):
         Maximum borrowing capacity                               $ 125.0
         Collateral reserves                                        (32.7)
         Letters of credit and other reserves                        (2.4)

         Current maximum borrowing capacity                          89.9
         Current borrowings                                         (89.2)
         Additional unrestricted borrowing capacity(a)            $   0.7
         (a) Subject to the cash dominion threshold noted above


On November 16, 2020, the Company announced it had reached an agreement in
principle with its first lien lender, PNC, and certain of its stockholders to
provide for a new $8.0 million term loan from such stockholders, subordinated
only to the Revolving A Credit Facility. As part of this agreement in principle,
the Company and PNC also agreed to extend the maturity date of the Revolving A
Credit Facility to February 28, 2023 and to amend certain aspects of the
facility to lower the minimum (on hand) liquidity requirement that the Company
must maintain by $3.8 million under the terms of the Revolving A Credit
Facility. Refer to Note 13 - Subsequent Events in the notes to the condensed
consolidated financial statements for further details.
On March 27, 2020, the Company completed the Exchange Offer to issue its the
3.00%/5.00% Convertible Notes and shares of its common stock in exchange for its
5.00%/7.00% Convertible Notes, including any accrued and unpaid interest on the
5.00%/7.00% Convertible Notes as of the date in which the Exchange Offer was
completed. Pursuant to the terms of the Exchange Offer, $190.2 million in
aggregate principal amount of the 5.00%/7.00% Convertible Notes were tendered
and accepted and in exchange, the Company issued $95.1 million in aggregate
principal amount of its 3.00%/5.00% Convertible Notes and 70,261 shares of its
common stock. An aggregate
                                       34
--------------------------------------------------------------------------------
  Table of Contents
principal amount of 5.00%/7.00% Convertible Notes in the amount of $3.7 million
were not tendered and remained outstanding at the date of Exchange Offer. As a
result of the Exchange Offer, the Company reduced the aggregate principal amount
of its long-term debt by $94.5 million and expects to reduce its annual interest
expense by over $10.0 million.
The 3.00%/5.00% Convertible Notes were issued pursuant to an indenture (the
"3.00%/5.00% Convertible Notes Indenture"), which the Company and the Guarantors
(defined below) entered into with Wilmington Savings Fund Society, FSB, as
trustee and collateral agent ("Indenture Agent"), on March 27, 2020. The
3.00%/5.00% Convertible Notes are, secured by a lien on all or substantially all
of the assets of the Company, its domestic subsidiaries and certain of its
foreign subsidiaries, which lien the Indenture Agent has agreed will be junior
to the lien of the Agent under the ABL Credit Agreement.
The 3.00%/5.00% Convertible Notes have substantially the same terms that the
5.00%/7.00% Convertible Notes had prior to the completion of the Exchange Offer,
except for the following primary differences: (i) the 3.00%/5.00% Convertible
Notes are not exempt from the registration requirements of the Securities Act
and have the benefit of registration rights to the holders of the 3.00%/5.00%
Convertible Notes, (ii) the interest on the 3.00%/5.00% Convertible Notes
accrues at the rate of 3.00% per annum if paid in cash and at the rate of 5.00%
per annum if paid in kind, compared to interest on the 5.00%/7.00% Convertible
Notes, which accrues at the rate of 5.00% per annum if paid in cash and at the
rate of 7.00% per annum if paid in kind, and (iii) the 3.00%/5.00% Convertible
Notes have a maturity date of August 31, 2024, compared to the 5.00%/7.00%
Convertible Notes, which have a maturity date of August 31, 2022.
In conjunction with the Exchange Offer, on March 27, 2020, the Company, the
guarantors of the 5.00%/7.00% Convertible Notes and the trustee for the
5.00%/7.00% Convertible Notes entered into a supplemental indenture to the
indenture governing the 5.00%/7.00% Convertible Notes (the "5.00%/7.00%
Convertible Notes Indenture") to provide for, among other things, the
elimination or amendment of substantially all of the restrictive covenants, the
release of all collateral securing the Company's obligations under the
5.00%/7.00% Convertible Notes Indenture, and the modification of certain of the
events of default and various other provisions contained in the 5.00%/7.00%
Convertible Notes Indenture.
Also on March 27, 2020, PNC (in its capacity as "First Lien Agent"), the trustee
for the 5.00%/7.00% Convertible Notes and the Company and certain of its
subsidiaries executed an intercreditor agreement (the "New Intercreditor
Agreement") providing for the lien priority of the first lien facility over the
3.00%/5.00% Convertible Notes. The terms and conditions of the New Intercreditor
Agreement are substantially consistent with those applicable to the
intercreditor agreement between the First Lien Agent and the trustee for the
5.00%/7.00% Convertible Notes prior to the completion of the Exchange Offer (the
"5.00%/7.00% Convertible Notes Intercreditor Agreement"). PNC and the trustee
for the 5.00%/7.00% Convertible Notes also entered into an amendment of the
5.00%/7.00% Convertible Notes Intercreditor Agreement to, among other things,
remove certain limitations and rights of the 5.00%/7.00% Convertible Notes with
respect to the first lien facility.
The 3.00%/5.00% Convertible Notes are convertible into shares of the Company's
common stock at any time at the initial conversion price of $0.46 per share,
which rate is subject to adjustment as set forth in the 3.00%/5.00% Convertible
Notes Indenture. Under the 3.00%/5.00% Convertible Notes Indenture, upon the
conversion of the 3.00%/5.00% Convertible Notes in connection with a Fundamental
Change (as defined in the 3.00%/5.00% Convertible Notes Indenture), for each
$1.00 principal amount of the 3.00%/5.00% Convertible Notes, that number of
shares of the Company's common stock issuable upon conversion shall equal the
greater of (a) $1.00 divided by the then applicable conversion price or (b)
$1.00 divided by the price paid per share of the Company's common stock in
connection with such Fundamental Change calculated in accordance with the
3.00%/5.00% Convertible Notes Indenture, subject to other provisions of the
3.00%/5.00% Convertible Notes Indenture. Subject to certain exceptions, under
the 3.00%/5.00% Convertible Notes Indenture a "Fundamental Change" includes, but
is not limited to, the following: (i) the acquisition of more than 50% of the
voting power of the Company's common equity by a "person" or "group" within the
meaning of Section 13(d) of the Securities Exchange Act of 1934, as amended;
(ii) the consummation of any recapitalization, reclassification, share exchange,
consolidation or merger of the Company pursuant to which the Company's common
stock will be converted into cash, securities or other property; (iii) the
"Continuing Directors" (as defined in the 3.00%/5.00% Convertible Notes
Indenture) cease to constitute at least a majority of the board of directors;
and (iv) the approval of any plan or proposal for the liquidation or dissolution
of the Company by the Company's stockholders.
The 5.00%/7.00% Convertible Notes are convertible into shares of the Company's
common stock at any time at the initial conversion price of $3.77 per share,
which rate is subject to adjustment as set forth in the Supplemental Indenture.
Under the Supplemental Indenture, the conversion of the 5.00%/7.00% Convertible
Notes in connection
                                       35
--------------------------------------------------------------------------------
  Table of Contents
with a Fundamental Change (as defined in the Supplemental Indenture) is
substantially the same as under the 3.00%/5.00% Convertible Notes Indenture,
other than the applicable conversion price.
Upon conversion of the 3.00%/5.00% Convertible Notes and/or the 5.00%/7.00%
Convertible Notes, the Company will pay and/or deliver, as the case may be,
cash, shares of the Company's common stock or a combination of cash and shares
of the Company's common stock, at the Company's election, together with cash in
lieu of fractional shares. The value of shares of the Company's common stock for
purposes of the settlement of the conversion right, if the Company elects to
settle in cash, will be calculated as provided in the 3.00%/5.00% Convertible
Notes Indenture or Supplemental Indenture, as applicable, using a 20 trading day
observation period.
As discussed previously, the 3.00%/5.00% Convertible Notes are convertible into
common stock at the option of the holder. The Company determined that the
conversion option is not clearly and closely related to the economic
characteristics of the 3.00%/5.00% Convertible Notes, nor does the conversion
option meet the own equity scope exception as the Company does not currently
have sufficient authorized and unissued common stock shares to satisfy the
maximum number of common stock shares that could be required to be issued upon
conversion. The initial value allocated to the derivative liability was $38,962,
with a corresponding reduction in the carrying value of the 3.00%/5.00%
Convertible Notes.
As a result of the Company's filing articles of amendment to increase the number
of shares of common stock authorized, the number of the Company's common stock
shares available for issuance upon conversion of the 3.00%/5.00% Convertible
Notes is sufficient to allow the conversion option to be share-settled in full.
The Company has concluded that as of June 30, 2020 the conversion option
qualifies for equity classification and the bifurcated derivative liability will
no longer need to be accounted for as a separate derivative on a prospective
basis from the date of reassessment. As of June 30, 2020, the fair value of the
conversion option of $36,952, was classified to equity as additional paid-in
capital. There was no tax impact of the reclassification of the conversion
option to equity. Any remaining debt discount that arose at the date of debt
issuance from the original bifurcation will continue to be amortized through
interest expense.
The terms of the 3.00%/5.00% Convertible Notes contain numerous covenants
imposing financial and operating restrictions on the Company's business. These
covenants place restrictions on the Company's ability and the ability of its
subsidiaries to, among other things, pay dividends, redeem stock or make other
distributions or restricted payments; incur indebtedness or issue certain stock;
make certain investments; create liens; agree to certain payment restrictions
affecting certain subsidiaries; sell or otherwise transfer or dispose assets;
enter into transactions with affiliates; and enter into sale and leaseback
transactions.
Neither the 3.00%/5.00% Convertible Notes nor the 5.00%/7.00% Convertible Notes
may be redeemed by the Company in whole or in part at any time prior to
maturity, except the Company may be required to make an offer to purchase the
3.00%/5.00% Convertible Notes using the proceeds of certain material asset sales
involving the Company or one of its restricted subsidiaries, as described more
particularly in the 3.00%/5.00% Convertible Notes Indenture. In addition, if a
Fundamental Change (as defined in the 3.00%/5.00% Convertible Notes Indenture
and the Supplemental Indenture, as applicable) occurs at any time, each holder
of any 3.00%/5.00% Convertible Notes or 5.00%/7.00% Convertible Notes has the
right to require the Company to repurchase such holder's notes for cash at a
repurchase price equal to 100% of the principal amount thereof, together with
accrued and unpaid interest thereon, subject to certain exceptions.
Indebtedness for borrowings under the 3.00%/5.00% Convertible Notes Indenture
and the Supplemental Indenture is subject to acceleration upon the occurrence of
specified defaults or events of default as set forth under each such indenture,
including failure to pay principal or interest, the inaccuracy of any
representation or warranty of any obligor, failure by an obligor to perform
certain covenants, the invalidity or impairment of the Agent's lien on its
collateral under the 3.00%/5.00% Convertible Notes Indenture, the invalidity or
impairment of any applicable guarantee, and certain adverse bankruptcy-related
and other events. Although the full extent that the COVID-19 pandemic will have
on the Company's business, operations and financial condition is currently
unknown, it does not anticipate that any specified defaults or events of default
as set forth in the indenture will occur during the next 12 months.
Upon satisfaction of certain conditions more particularly described in the
3.00%/5.00% Convertible Notes Indenture, including the deposit in trust of cash
or securities sufficient to pay the principal of and interest and any premium on
the 3.00%/5.00% Convertible Notes, the Company may effect a covenant defeasance
of certain of the covenants imposing financial and operating restrictions on the
Company's business. In addition, and subject to certain exceptions as more
particularly described in the 3.00%/5.00% Convertible Notes Indenture, the
Company may amend, supplement or waive provisions of the 3.00%/5.00% Convertible
Notes Indenture with the consent of
                                       36
--------------------------------------------------------------------------------
  Table of Contents
holders representing a majority in aggregate principal amount of the 3.00%/5.00%
Convertible Notes, and may in effect release collateral from the liens securing
the 3.00%/5.00% Convertible Notes with the consent of holders representing
66-2/3% in aggregate principal amount of the 3.00%/5.00% Convertible Notes.
Interest on the 3.00%/5.00% Convertible Notes accrues at the rate of 3.00% per
annum if paid in cash and at the rate of 5.00% per annum if paid in kind,
payable quarterly. Interest on the 5.00%/7.00% Convertible Notes continues to
accrue at the rate of 5.00% per annum if paid in cash and at the rate of 7.00%
per annum if paid in kind, payable quarterly. Pursuant to the terms of both the
3.00%/5.00% Convertible Notes Indenture and the Supplemental Indenture, the
Company is currently paying interest on both the 3.00%/5.00% Convertible Notes
and the 5.00%/7.00% Convertible Notes in kind.
Summarized Parent and Guarantor Financial Information
As discussed above, the 3.00%/5.00% Convertible Notes issued by A.M. Castle and
Co. (the "Parent") are unconditionally guaranteed on a joint and several basis
by all current and future domestic subsidiaries of the Parent (other than those
designated as unrestricted subsidiaries) and the parent's subsidiaries in Canada
and Mexico (collectively, the "Guarantors"). Each guarantor is 100% owned by the
Parent.
The guarantees of the Guarantors are subject to release in limited
circumstances, only upon the occurrence of certain customary conditions. There
are no significant restrictions on the ability of the parent company or any
guarantor to obtain funds from its subsidiaries by dividend or loan.
On March 31, 2020, the Company early adopted the guidance of the SEC Final Rule
Release No. 33-10762, "Financial Disclosures About Guarantors and Issuers of
Guaranteed Securities and Affiliates Whose Securities Collateralize a
Registrant's Securities" (the "final rule") and has elected to present the
summarized financial information of Parent and Guarantors (together, the
"Obligors") as of and for the six months ended September 30, 2020 and as of and
for the year ended December 31, 2019 (see Note 2 - New Accounting Standards, to
the notes to the condensed consolidated financial statements for further
information on the final rule).
The summarized financial information of the Obligors after elimination of (i)
intercompany transactions and balances among the Parent and the Guarantors and
(ii) equity in earnings from and investments in any subsidiary that is a
Non-Guarantor follows:
                                                                        Obligors
                                                   As of and for the Nine          As of and for the
                                                        Months Ended                  Year Ended
(in millions)                                        September 30, 2020            December 31, 2019
Total current assets                               $              172.0          $            192.4
Total non-current assets (1)                                      128.0                       134.4
Total current liabilities                                          55.0                        54.9
Total non-current liabilities (1)                                 253.3                       313.0
Net sales                                                         246.0                       453.1
Total costs and expenses                                          264.3                       467.1
Operating loss                                                     18.2                        14.0

Net loss                                                           29.8                        38.5


(1) Included in non-current assets are $10.8 million and $12.2 million of
non-current intercompany receivables due to the Obligors from the Non-Guarantors
as of September 30, 2020 and December 31, 2019, respectively. Included in
non-current liabilities are $7.5 million and $8.6 million of non-current
intercompany payables due to the Non-Guarantors from the Obligors as of
September 30, 2020 and December 31, 2019, respectively.
Other Credit Facilities
In July 2017, the Company's French subsidiary entered into a local credit
facility under which it may borrow against 100% of the eligible accounts
receivable factored, with recourse, up to 6.5 million Euros, subject to
factoring fees and floating Euribor or LIBOR interest rates, plus a 1.0% margin.
The French subsidiary utilizes the local credit facility to support its
operating cash needs. As of September 30, 2020, the French subsidiary had no
borrowings under the local credit facility and had borrowings under the local
credit facility of $2.9 million as of December 31, 2019. The Company records
borrowings under the local credit facility as short-term borrowings at the
Condensed Consolidated Balance Sheets.
                                       37
--------------------------------------------------------------------------------
  Table of Contents
On July 20, 2020, the Company's Chinese subsidiary entered into a $3.0 million
local banking line of credit with the Bank of Communication Shanghai (the "China
Credit Facility"). The China Credit Facility has an initial maturity date of
January 20, 2021 and accrues interest at a rate of 3.6% per annum. As of
September 30, 2020, the Chinese subsidiary had borrowings of $2.0 million
outstanding under the China Credit Facility.
Interest expense in the nine months ended September 30, 2020 and the nine months
ended September 30, 2019 was $20.1 million and $29.5 million, respectively, of
which $3.7 million and $5.2 million, respectively, was cash interest.
As of September 30, 2020, the Company had $2.4 million of irrevocable letters of
credit outstanding.
For additional information regarding the terms of the ABL Credit Agreement, the
3.00%/5.00% Convertible Notes, the 5.00%/7.00% Convertible Notes and the
Company's foreign credit facility, refer to Note 6 - Debt to the Notes to the
Condensed Consolidated Financial Statements.
Critical Accounting Policies
The preparation of our financial statements requires us to make estimates,
judgments and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenue and expenses during
the reporting period. Part II, Item 7 of the Company's Annual Report on Form
10-K for the fiscal year ended December 31, 2019 includes a summary of the
critical accounting policies we believe are the most important to aid in
understanding our financial results. There have been no changes to those
critical accounting policies that have had a material impact on our reported
amounts of assets, liabilities, revenues or expenses during the nine months
ended September 30, 2020.
                                       38

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses